These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38308430)

  • 1. Screening and characterization of aptamers recognizing the periodontal pathogen Tannerella forsythia.
    Mizgalska D; Malicki S; Golda A; Chruścicka-Smaga B; Potempa J
    FEBS Open Bio; 2024 Mar; 14(3):498-504. PubMed ID: 38308430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latency, thermal stability, and identification of an inhibitory compound of mirolysin, a secretory protease of the human periodontopathogen
    Zak KM; Bostock MJ; Waligorska I; Thøgersen IB; Enghild JJ; Popowicz GM; Grudnik P; Potempa J; Ksiazek M
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1267-1281. PubMed ID: 34210221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage inducible C-type lectin (Mincle) recognizes glycosylated surface (S)-layer of the periodontal pathogen Tannerella forsythia.
    Chinthamani S; Settem RP; Honma K; Kay JG; Sharma A
    PLoS One; 2017; 12(3):e0173394. PubMed ID: 28264048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo expression of proteases and protease inhibitor, a serpin, by periodontal pathogens at teeth and implants.
    Eckert M; Mizgalska D; Sculean A; Potempa J; Stavropoulos A; Eick S
    Mol Oral Microbiol; 2018 Jun; 33(3):240-248. PubMed ID: 29498485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Metalloproteinase Mirolysin of Tannerella forsythia Inhibits All Pathways of the Complement System.
    Jusko M; Potempa J; Mizgalska D; Bielecka E; Ksiazek M; Riesbeck K; Garred P; Eick S; Blom AM
    J Immunol; 2015 Sep; 195(5):2231-40. PubMed ID: 26209620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multispecies biofilm behavior and host interaction support the association of Tannerella serpentiformis with periodontal health.
    Kendlbacher FL; Bloch S; Hager-Mair FF; Bacher J; Janesch B; Thurnheer T; Andrukhov O; Schäffer C
    Mol Oral Microbiol; 2023 Apr; 38(2):115-133. PubMed ID: 35964247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tannerella forsythia-produced methylglyoxal causes accumulation of advanced glycation endproducts to trigger cytokine secretion in human monocytes.
    Settem RP; Honma K; Shankar M; Li M; LaMonte M; Xu D; Genco RJ; Browne RW; Sharma A
    Mol Oral Microbiol; 2018 Aug; 33(4):292-299. PubMed ID: 29573211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome and immune responses of extracellular vesicles derived from macrophages infected with the periodontal pathogen Tannerella forsythia.
    Lim Y; Kim HY; Han D; Choi BK
    J Extracell Vesicles; 2023 Dec; 12(12):e12381. PubMed ID: 38014595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genome characterization of the periodontal pathogen Tannerella forsythia.
    Zwickl NF; Stralis-Pavese N; Schäffer C; Dohm JC; Himmelbauer H
    BMC Genomics; 2020 Feb; 21(1):150. PubMed ID: 32046654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of a chymotrypsin-like serine protease from periodontal pathogen, Tannerella forsythia.
    Hockensmith K; Dillard K; Sanders B; Harville BA
    Microb Pathog; 2016 Nov; 100():37-42. PubMed ID: 27594668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periodontopathogens and human β-defensin-2 expression in gingival crevicular fluid from patients with periodontal disease in Guangxi, China.
    Yong X; Chen Y; Tao R; Zeng Q; Liu Z; Jiang L; Ye L; Lin X
    J Periodontal Res; 2015 Jun; 50(3):403-10. PubMed ID: 25065393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gingipain-dependent augmentation by Porphyromonas gingivalis of phagocytosis of Tannerella forsythia.
    Jung YJ; Jun HK; Choi BK
    Mol Oral Microbiol; 2016 Dec; 31(6):457-471. PubMed ID: 26434368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An IgY-based immunoassay to evaluate the biomarker potential of the Tannerella forsythia virulence factor karilysin in human saliva.
    Skottrup PD; López R; Ksiazek M; Højrup P; Baelum V; Potempa J; Kaczmarek JZ
    J Immunol Methods; 2019 Jun; 469():26-32. PubMed ID: 30880264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique miRomics Expression Profiles in
    Aravindraja C; Jeepipalli S; Duncan W; Vekariya KM; Bahadekar S; Chan EKL; Kesavalu L
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003583
    [No Abstract]   [Full Text] [Related]  

  • 15. Peptidoglycan-type analysis of the N-acetylmuramic acid auxotrophic oral pathogen Tannerella forsythia and reclassification of the peptidoglycan-type of Porphyromonas gingivalis.
    Mayer VMT; Hottmann I; Figl R; Altmann F; Mayer C; Schäffer C
    BMC Microbiol; 2019 Sep; 19(1):200. PubMed ID: 31477019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an α-l-fucosidase from the periodontal pathogen Tannerella forsythia.
    Megson ZA; Koerdt A; Schuster H; Ludwig R; Janesch B; Frey A; Naylor K; Wilson IB; Stafford GP; Messner P; Schäffer C
    Virulence; 2015; 6(3):282-92. PubMed ID: 25831954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptidoglycan Salvage Enables the Periodontal Pathogen Tannerella forsythia to Survive within the Oral Microbial Community.
    Hottmann I; Borisova M; Schäffer C; Mayer C
    Microb Physiol; 2021; 31(2):123-134. PubMed ID: 34107471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavior of two Tannerella forsythia strains and their cell surface mutants in multispecies oral biofilms.
    Bloch S; Thurnheer T; Murakami Y; Belibasakis GN; Schäffer C
    Mol Oral Microbiol; 2017 Oct; 32(5):404-418. PubMed ID: 28382776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17.
    Jung YJ; Choi YJ; An SJ; Lee HR; Jun HK; Choi BK
    Mol Oral Microbiol; 2017 Aug; 32(4):301-313. PubMed ID: 27484636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on clinical outcomes of adjunctive moxifloxacin versus amoxicillin plus metronidazole in periodontitis patients harboring Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythia: exploratory analyses from a clinical trial.
    Ardila CM; Hernández-Casas C; Bedoya-García JA
    Quintessence Int; 2021; 52(1):20-29. PubMed ID: 32696031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.